Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

LaVoieHealthScience Bolsters Commercial Strategic Communications Expertise with the Hiring of Deborah Plumstead as Vice President


LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of Deborah Plumstead as Vice President of Health Communications. Ms. Plumstead brings over 20 years of experience leading product and corporate public relations initiatives for companies in the pharmaceutical, biotechnology, and medical device sectors. She has worked across a range of medical and therapeutic areas, including oncology, ophthalmology, rare disease, neuroscience, rheumatology, infectious diseases, and women's health. Ms. Plumstead brings expertise in commercial strategic communications programming and execution from pharma to biopharma and beyond.

Prior to joining LHS, Ms. Plumstead was Vice President, Client Navigation at Green Room Communications, a national healthcare public relations agency. In that role, she managed the strategy and execution of pre-commercial and regulatory communications, patient advocacy campaigns, and thought leadership programs. Prior to that position, she served as a senior communications consultant for healthcare non-profits including the American Nurses Foundation, Kennedy Krieger Institute, and the American Pharmacists Association. Ms. Plumstead started her career in public affairs with Burson-Marsteller's Washington, DC office. Subsequently, she spent 12 years working overseas for global public relations agencies and boutique consultancies in the United Arab Emirates, Qatar, Trinidad, Russia, Ukraine, and Kazakhstan.

Donna L. LaVoie, President & CEO of LHS said, "We're thrilled to welcome Deborah to our team as we continue to support our clients' growth toward commercialization. Our clients and team will benefit from her deep communications and agency experience as a public relations strategic leader in the health and science industry. Her joining bolsters the firm's expertise in pre-commercial and commercial strategic communications programming and execution."

Deborah Plumstead said, "The growth and recognition of LaVoieHealthScience is a testament to the agency's expertise and its value to clients. I am excited to join a team with such breadth of experience and unmatched passion for advancing health and science innovations. The role of health communications has never been more critical, and I look forward to helping our clients advance the significant work they are doing."

Photo available here.

About LaVoieHealthScience
LaVoieHealthScience advances health and science innovations through strategic communications. We offer fully integrated public relations, investor relations, marketing, and digital services. We have been in business for 20 years, have won over 50 public relations and investor relations awards, developed over 325 communications plans, and have doubled the size of the agency since 2017.


These press releases may also interest you

at 03:00
Uniform Advantage (UA), a multi-channel retailer of medical uniforms for medical and hospitality industries, is proud to continue its partnership with the Breast Cancer Research Foundation® (BCRF) with a $20,000 donation. "Uniform...

30 sep 2022
Tanger Factory Outlet Centers, Inc.  announces the launch of its annual Pink campaign this October, building upon the company's commitment to breast cancer research and local breast cancer support groups within the communities it serves. Tanger...

30 sep 2022
Lug, the popular lifestyle brand of handbags and accessories, is pleased to announce its 3-year commitment to the SickKids Foundation in support of The Hospital for Sick Children. Through our Lug Cares Program, Lug is committed to supporting and...

30 sep 2022
October is pregnancy and infant loss awareness month with the Butterfly Run kicking off the month on October 1st with a 5 km and 3 km run/walk to raise awareness about these often-silent losses. The run raises funds to help support those who have...

30 sep 2022
Regulatory News: Aptorum Group Limited ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...

30 sep 2022
Technavio's latest offering, the Motion Sickness Drugs Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The motion sickness drugs market value is anticipated to grow by USD 119.64...



News published on 16 august 2022 at 13:05 and distributed by: